Pre-symptomatic treatment with creatine in AGAT- and GAMT-deficiencies, in fact, did prevent further development of central nervous system symptoms in CCDS patients (Battini et al., 2006; Schulze et al., 2006). The gene discussed is GAMT; the disease is cerebral creatine deficiency syndrome.